A controlled trial of mazindol (Sanjorex, Teronac) in the management of the obese rheumatic patients.
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004038:Diet, Reducing; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D007211:Indoles / Q000008:administration & dosage / Q000627:therapeutic use*; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D010003:Osteoarthritis / Q000150:complications / Q000188:drug therapy*; D010919:Placebos; D012459:Salicylates / Q000627:therapeutic use; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D007093:Imidazoles; D007211:Indoles; D010919:Placebos; D012459:Salicylates; D007213:Indomethacin